Device / Technology News

RSS

BSD's MicroThermX Microwave Ablation System featured at CIRSE

BSD Medical Corporation announced today that the MicroThermX Microwave Ablation System was featured at the Company's exhibition booth at the international meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), which was held in Valencia, Spain, October 2-6, 2010.

15 Oct 2010

Applied Skin Technology launches three revolutionary products for skin damage

Applied Skin Technology announces the launch of three breakthrough moisturizers, harnessing cutting-edge skin care technology, and using the most effective skin restoring ingredients available. These revolutionary products are formulated for three different categories: women, men, and a recovery cream for skin that has been damaged due to a medical condition or the side effect of medical treatment.

15 Oct 2010

VertiFlex enrolls patients in Superion IDE clinical trial

VertiFlex, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced that 200 patients have been enrolled in its pivotal IDE clinical trial of the Superion Interspinous Spacer (ISS).

15 Oct 2010

New, affordable technology for cervical cancer screening

Current cervical cancer screening is time consuming and expensive, but now new breakthrough technology developed by European researchers should allow large-range screening by non-medical personnel with almost immediate results and at a much lower cost.

15 Oct 2010

Lantheus announces Canadian launch of ABLAVAR injection

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent.

15 Oct 2010

BIOTRONIK announces European release of TI Trend Chart

BIOTRONIK SE Co. & KG, leading manufacturer of cardiovascular devices, has announced the European release of its Thoracic Impedance (TI) Trend Chart via its pioneering BIOTRONIK Home Monitoring technology and Lumax 540 implantable cardiac defibrillator (ICD) series.

15 Oct 2010

FDG positron emission tomography allows early diagnosis of gall bladder cancer

Researchers at the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.

15 Oct 2010

NIH awards two new grants to develop Avidocin platform

AvidBiotics today announced the receipt of two new grants totaling $1 million dollars from the National Institutes of Health that further the development of the company's novel Avidocin™ platform for narrow spectrum antibacterial proteins against important health care threats. These grants add to three previous grants covering AvidBiotics' anti-infectious disease technologies, which provide approximately $3.4 million in currently active funding for the company.

15 Oct 2010

Robot-assisted brachytherapy for treating prostate cancer

In the first-of-a-kind clinical trial, a robot will be used to place therapeutic radioactive seeds in prostate cancer patients. The National Cancer Institute-supported study, which will enroll 14 patients, has just opened at Thomas Jefferson University Hospital.

15 Oct 2010

Allure Medical Spa to offer FDA approved Coolsculpting by Zeltiq for non-invasive fat reduction

Great news for men and women dealing with exercise and diet-resistant fat in areas like the tummy, love handles and back rolls! Allure Medical Spa of Shelby Township is the first in Southeastern Michigan to offer Coolsculpting by Zeltiq, the first ever procedure approved by the U.S. Food and Drug Administration (Sept. 8, 2010), for the non-invasive reduction of fat. Coolsculpting by Zeltiq is a virtually painless procedure that reduces fat cells with no needles, surgery or downtime.

15 Oct 2010

TruStaff fingerprint biometric log-in provides quick access to Medflow EHR

BIO-key International, Inc. a leader in finger-based biometric identification solutions for the healthcare industry, and Medflow Incorporated, the market leader in the development of electronic health records software solely dedicated to eye care physicians, announced the release of TruStaff fingerprint biometric log-in for securing access to Medflow Electronic Health Records (EHR).

14 Oct 2010

Verizon introduces new IT consulting services for health care providers

In its continuing efforts to help the health care industry accelerate the use of electronic medical records, Verizon is expanding its Medical Data Exchange platform to allow more types of digital patient health data to be shared.

14 Oct 2010

IMD receives EPO patent for NADiA ultra-sensitive protein detection and cell phenotyping platform

IRIS International, Inc. a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that Iris Molecular Diagnostics (IMD)has been granted Patent No. EP1842226B1 by the European Patent Office (EPO) covering aspects of IMD's NADiA ultra-sensitive protein detection and cell phenotyping platform, which can detect proteins in the femtogram (1 quadrillionth) per milliter range and phenotype single cells.

14 Oct 2010

Biodar Plus to provide INVO Bioscience's infertility treatments and distribute INVOcell device across Ukraine

INVO Bioscience, Inc., a medical device company focused on treatment options for patients diagnosed with infertility, today announced the signing of an exclusive sales and distribution agreement with the Biodar Plus Company, based in Donetsk, Ukraine to distribute the INVOcell product throughout Ukraine and to provide the INVO Bioscience infertility treatments in its in-house infertility center.

14 Oct 2010

Dehaier exhibits entire product line at China International Medical Equipment Fair

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that on October 12, 2010, Dehaier exhibited its entire product line at the China International Medical Equipment Fair ("CMEF") held in Shenyang.

14 Oct 2010

2010 IMV ServiceTrak Imaging report on CT scanners provides top rankings to Toshiba Service

When it comes to diagnostic imaging, today's healthcare facilities seek the best value in imaging and customer service. Toshiba America Medical Systems, Inc.'s Service organization is committed to meeting this need by delivering top-tier service and has outscored the industry in 33 out of 40 attributes, 26 of which were number one rankings, in the 2010 IMV ServiceTrak™ Imaging report on CT scanners. IMV, Ltd. provides an independent analysis of service trends in the imaging industry.

14 Oct 2010

Childrens Hospital Los Angeles receives $1M NCI grant for eye port clinical trial to treat retinoblastoma in children

The Vision Center at Childrens Hospital Los Angeles has been awarded a $1 million grant from the National Cancer Institute (NCI) to conduct a clinical trial on a new drug delivery system to treat young children diagnosed with retinoblastoma. The device is designed to deliver chemotherapy through a tiny silicone cup sealed to the outer surface (sclera) of the eye, which can more directly target cancer cells and greatly reduce the side effects caused by current chemotherapy treatments.

14 Oct 2010

EFNS recommends use of DaTSCAN injection with SPECT imaging for AD diagnosis

GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.

14 Oct 2010

Top citations for scientific paper on Inovio's SynCon DNA vaccines and ID DNA delivery technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a scientific paper demonstrating strong and protective immune responses from candidate SynCon™ DNA vaccines in preclinical studies using Inovio's intradermal (ID) DNA delivery technology was one of the top cited scientific articles in the past three years in the journal Vaccine.

14 Oct 2010

New filtering technology kills disease-causing bacteria without clogging

With almost one billion people lacking access to clean, safe drinking water, scientists are reporting development and successful initial tests of an inexpensive new filtering technology that kills up to 98 percent of disease-causing bacteria in water in seconds without clogging. A report on the technology appears in Nano Letters, a monthly American Chemical Society journal.

14 Oct 2010